Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells-Reference-Cited by-同舟云学术

Mucosal administration of an altered CII263-272 peptide inhibits collagen-induced arthritis by suppression of Th1/Th17 cells and expansion of regulatory T cells

Published:2008-07-05 Issue:1 Volume:29 Page:9-16
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Zhao Jinxia,Li Ru,He Jing,Shi Jinxia,Long Li,Li Zhanguo

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-008-0634-4.pdf

Reference40 articles.

1. VanderBorght A, Geusens P, Raus J, Stinissen P (2001) The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and immunotherapies. Semin Arthritis Rheum 31:160–175. doi: 10.1053/sarh.2001.27736

2. Myers LK, Sakurai Y, Tang B, He X, Rosloniec EF, Stuart JM et al (2002) Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice. Arthritis Rheum 46:3369–3377. doi: 10.1002/art.10687

3. Zhou Q, Cheng YJ, Lü H, Zhou WH, Li ZG (2003) Inhibition of T cell activation with HLA-DR1/DR4 restricted non-T cell recognizing peptides. Hum Immunol 64:857–865. doi: 10.1016/S0198-8859(03)00143-5

4. Cheng YJ, Zhou Q, Li ZG (2005) The inhibitory effect of altered collagen II peptide on HLA-RB1-restricted T cell activation. Scand J Immunol 61:260–265. doi: 10.1111/j.1365-3083.2005.01553.x

5. Li R, Li X, Li ZG (2006) Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis. Clin Immunol 118:317–233. doi: 10.1016/j.clim.2005.09.020

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Organoruthenium 9E1 and APL Altered Collagen II263-272 Peptide as Therapy for Autoimmune Diseases;Journal of Health Science and Medical Therapy;2023-09-28

2. A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation;Frontiers in Immunology;2023-04-28

3. Peptide-Based Vaccination Therapy for Rheumatic Diseases;Journal of Immunology Research;2020-03-18

4. CIGB-814, an altered peptide ligand derived from human heat-shock protein 60, decreases anti-cyclic citrullinated peptides antibodies in patients with rheumatoid arthritis;Clinical Rheumatology;2018-11-10

5. Recent advances in the development of vaccines for chronic inflammatory autoimmune diseases;Vaccine;2018-05